A Multicenter Active Comparator Study of HC-ER in Adults Following Bunionectomy Surgery

NCT02197156 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

241

Enrollment

INDUSTRY

Sponsor class

Conditions

Postoperative Pain

Interventions

DRUG: 10 mg HC-ER
DRUG: 20 mg HC-ER
DRUG: 30 mg HC-ER
DRUG: 40 mg HC-ER
DRUG: 10 mg HC / 325 mg APAP
DRUG: Matching Placebo

Sponsor

Zogenix, Inc.